以李东垣阴火学说论治快速性心律失常的理论探讨及临床研究
|
摘要
背景:快速性心律失常是临床上的常见病,重者可导致猝死。目前中医药虽在治疗部分快速性心律失常中显示了良好的临床疗效,但也存在辨证论治方法单一、理论和实践脱节等不足。本研究归纳总结了运用金元时代临床家李东垣阴火学说辨证论治快速性心律失常临床经验,希望能够丰富心律失常的中医辨证论治体系,在中医理论和实践方面有所创新。目的:从理论及临床两个方面,探讨李东垣“阴火”学说在快速性心律失常发病中的作用和机理,以及以益气、祛火、养阴为主的治疗方法在快速性心律失常中的重要地位,为心律失常的治疗提供新的理论指导和治疗方法。方法:通过系统的文献回顾和理论探讨,提出“脾虚气陷,阴火内生”是快速性心律失常的重要病机,系统总结了快速性心律失常阴火证的不同治疗方法,并以“益气升阳,泻火养阴”立法,使用宁心定悸合剂对冠心病所致早搏(阴火上冲型)患者进行系统的临床治疗观察,并与参松养心胶囊进行对照。结果:1.宁心定悸合剂组治疗冠心病所致早搏(阴火上冲型)总有效率为89.13%,参松养心胶囊组总有效率为60.87%,两组比较有显著性差异(P<0.01)。2.宁心定悸合剂试验组改善患者整体症状总有效率为86.96%,参松养心胶囊对照组总有效率为43.48%,两组比较有显著性差异(P<0.01)。3.宁心定悸合剂组与对照组比较,在改善心肌缺血,缓解焦虑、抑郁情绪,提高心率变异,降低NT-proBNP水平,改善心功能等方面都有较好的疗效。结论:以李东垣阴火学说论治快速性心律失常方法可行,以“益气升阳,泻火养阴”法治疗冠心病所致早搏(阴火上冲型)疗效确切。
Background:Arrhythmia is a clinical familiar disease,the sever degree may put the patient in danger of sudden death. At present TCM shows favorable clinic effect on part of tachyarrhythmia, however, it has some shortages such as single way in syndrome differentiation and treatment, losing contact between theory and practice, etc. This research conclude and summarize the clinic experience of syndrome differentiation and treatment of tachyarrhythmia system with“Yin-Fire”theory of the famous Climician in Jinyuan Dynasty Dongyuan Li. Hope to enrich the syndrome differentiation and treatment of tachyarrhythmia system and bring forth some new ideas in theory and practice of Chinese Traditional Madicine. Object: From theory and clinic, discuss the uses and principle of treating Tachyarrhythmia with Dong-yuan Li’s“Yin-Fire”theory, and discuss the importance of treating tachyarrhythmia mainly with replenishing qi, clearing heat and nourishing yin, aim to provide new theory and clinical method for treatment . Methods: Through literature system reviewing and theory discussing, raising“Qi sinking due to deficiency in spleen and Yin-Fire arising in Vivo”is the important pathogenesis of arrhythmia, summarizing in system the different clinical methods of arrhythmia with the characteristic of Yin-Fire. Use the treatment—Replenishing Qi and Elevating Yang, Heat Purging Fire and Nourishing Yin. Use Ningxindingji Mixture to treat the premature beat patients resulted by coronary heart disease (Yin-Fire uprush type) and observe systemly, and compare with Shensongyangxin Capsule. Results: 1.The total effect rate of the Ningxindingji Mixture group in treating tachyarrhythmia was 89.13%, which was evidently higher than that of the control group of 60.87%(P<0.01). 2.The total effect rate of ameliorating symptom of the Ningxindingji Mixture group was 86.96%, which was obviously superior of that of the control group of 43.48%(P<0.01). 3.The curative group had remarkable effect upon improving myocardial ischemia, relaxing the anxiety and depression, improving HRV, decreasing NT-proBNP, improving cardiac function,etc. Conclusion: The method of treating Tachyarrhythmia with Dong-yuan Li’s“Yin-Fire”theory is workable, and it is effective to treat the premature beat patients resulted by coronary heart disease (Yin-Fire uprush type) with Replenishing Qi and Elevating Yang, Heat Purging Fire and Nourishing Yin.
Background:Arrhythmia is a clinical familiar disease,the sever degree may put the patient in danger of sudden death. At present TCM shows favorable clinic effect on part of tachyarrhythmia, however, it has some shortages such as single way in syndrome differentiation and treatment, losing contact between theory and practice, etc. This research conclude and summarize the clinic experience of syndrome differentiation and treatment of tachyarrhythmia system with“Yin-Fire”theory of the famous Climician in Jinyuan Dynasty Dongyuan Li. Hope to enrich the syndrome differentiation and treatment of tachyarrhythmia system and bring forth some new ideas in theory and practice of Chinese Traditional Madicine. Object: From theory and clinic, discuss the uses and principle of treating Tachyarrhythmia with Dong-yuan Li’s“Yin-Fire”theory, and discuss the importance of treating tachyarrhythmia mainly with replenishing qi, clearing heat and nourishing yin, aim to provide new theory and clinical method for treatment . Methods: Through literature system reviewing and theory discussing, raising“Qi sinking due to deficiency in spleen and Yin-Fire arising in Vivo”is the important pathogenesis of arrhythmia, summarizing in system the different clinical methods of arrhythmia with the characteristic of Yin-Fire. Use the treatment—Replenishing Qi and Elevating Yang, Heat Purging Fire and Nourishing Yin. Use Ningxindingji Mixture to treat the premature beat patients resulted by coronary heart disease (Yin-Fire uprush type) and observe systemly, and compare with Shensongyangxin Capsule. Results: 1.The total effect rate of the Ningxindingji Mixture group in treating tachyarrhythmia was 89.13%, which was evidently higher than that of the control group of 60.87%(P<0.01). 2.The total effect rate of ameliorating symptom of the Ningxindingji Mixture group was 86.96%, which was obviously superior of that of the control group of 43.48%(P<0.01). 3.The curative group had remarkable effect upon improving myocardial ischemia, relaxing the anxiety and depression, improving HRV, decreasing NT-proBNP, improving cardiac function,etc. Conclusion: The method of treating Tachyarrhythmia with Dong-yuan Li’s“Yin-Fire”theory is workable, and it is effective to treat the premature beat patients resulted by coronary heart disease (Yin-Fire uprush type) with Replenishing Qi and Elevating Yang, Heat Purging Fire and Nourishing Yin.
引文
[1]王吉耀.全国高等医药教材建设研究会规划教材:内科学.北京:人民卫生出版社,2005,第一版:196-199
[2]胡大一.抗心律失常药物的合理应用.北京:中国环境出版社,1997,第一版:1
[3] Huikuri HV,Castellanos A,Myerburg RJ. Sudden death due to cardiac arrhyt mias.N Engl J Med, 2001, 345: 1473-1482.
[4] Chugh SS Jui J,Gunson K,et al.Current burden of sudden cardiac death:multiple source surveillance versus retrospective death certicate-based review in a large U.S.community.J Am Coll Cardiol 2004,44:1268-1275
[5]张年顺等.李东垣医学全书.北京:中国中医药出版社,2006,第一版:336
[6]金·李东垣撰.文魁,丁国华整理.脾胃论.北京:人民卫生出版社,2005,第一版:8
[7]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:441
[8]张年顺等.李东垣医学全书.北京:中国中医药出版社,2006,第一版:336
[9]张年顺.释“阴火”.河南中医,1983,2(2):17
[10]金·李东垣撰.文魁,丁国华整理.脾胃论.北京:人民卫生出版社,2005,第一版:97
[11]姜春华.姜春华论医集.福州:福建科学技术出版社,1982,第一版:305
[12]宋乃光.刘完素医学全书.北京:中国中医药出版社.2006,第一版:312-314
[13]程畅和,朱向东.相火理论源流考辨.甘肃中医学院学报,2003,20(3):12- 14
[14]郑洪新.张元素医学全书.北京:中国中医药出版社,2006,第一版:83-85
[15]王新华.中国历代医话选.南京:江苏科学技术出版社.1983,第一版:203
[16]印会河.高等医药院校教材:中医基础理论.上海:上海科学技术出版社,1984,第一版:42-43
[17]元·朱震亨.格致余论.沈阳:辽宁科学技术出版社,1997,第一版:1
[18]清·莫枚士.研经言·君火相火辨.南京:江苏科学技术出版社:11
[19]张年顺等.李东垣医学全书.北京:中国中医药出版社,2006,第1版:337
[20]程畅和,朱向东.相火理论源流考辨.甘肃中医学院学报,2003,20(3):12- 14
[21]杨卫东.东垣“阴火”与丹溪“相火”之异同.中医研究,2006,19(8):3- 4
[22]周亚萍,赵国仁.阴火与相火的关系辨析.浙江中医杂志,2007,42(3):127-128
[23]张年顺.释“阴火”.河南中医,1983,2(2):17
[24]郭刚,陆春玲.心脏病从脾胃论治,中国中西医结合脾胃杂志,2000, (8)6:453
[25]周文献.心病从脾(胃)论治探析,中医研究,2001, 6(14): 9
[26]李连成,高荣林.从脾胃论治胸痹的理论意义.中国中医基础医学杂志,1996,4(1):38
[27]丁光迪.东垣学说论文集.北京:人民卫生出版社,1984,第一版:10
[28]金·李东垣撰.文魁,丁国华整理.脾胃论.北京:人民卫生出版社,2005,第一版:97
[29]丁光迪.东垣学说论文集.北京:人民卫生出版社,1984,第一版:11-89
[30]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:138
[31]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:135
[32]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:131-139
[33]中华人民共和国卫生部制定发布.中药新药临床研究指导原则(第二辑).中药新药治疗心悸的临床研究指导原则:91
[34]国际心脏病学会和协会及WHO临床命名标准化联合专题组.缺血性心脏病命名及诊断标准.中华心血管病杂志,1981,9(1)∶75-76.
[35]中西医结合防治冠心病心绞痛、心律失常研究座谈会制定.常见心律失常、严重程度及疗效参考标准,上海,1979年
[36]陈灏珠.实用内科学,第12版.北京:人民卫生出版社,2005,第一版:1366-1367
[37]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[38]中华人民共和国卫生部.中药新药临床研究指导原则(第二辑).1995:91
[39]国家中医药管理局胸痹急症协作组.胸痹心悸(冠心病心律失常)中医急症诊疗规范.中国中医急症,1995,4(4):181-189
[40]中华人民共和国卫生部.中药新药临床研究指导原则(第二辑).1995:91
[41]吴以岭,谷春华,高学东,等.参松养心胶囊治疗冠心病室性早搏的随机双盲多中心临床研究.疑难病杂志,2007,8(6):449-452
[42]中华心血管病杂志编委会心率变异性对策专题组.心率变异性检测临床应用的建议.中华心血管病杂志,1998,26(4):252-255
[43]中华人民共和国卫生部.中药新药临床研究指导原则(第二辑).1995:91
[44]张钊,杨守忠,毛绍芬.参龙宁心胶囊联合阿替洛尔治疗冠心病心律失常临床研究.光明中医,2008,4(23):479
[45]中华人民共和国卫生部.中药新药临床研究指导原则.第一辑.1993:29
[46]陈可冀.心脑血管研究.上海:上海科技出版社,1998,第一版:311
[47]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:236-253
[48]路英智,张勤锋,田明萍.33例功能性消化不良的心理检测和治疗.中国行为医学科学,2000,5(9):19-20
[49]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:235
[50]王薇,赵冬.我国心血管病及其主要危险因素的流行病学研究.首都医科大学学报,2005,2(26):140-146
[51] Pedoe T H, Kuulasmaa K, Mahonen M, et al. Contribution of survival and coronary-event rates tochanges in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations.Lancet, 1999,353:1547-1557
[52] Thorvaldsen P, Kuulasmaa K, Rajakangas A M, et al. Stroke trends in the WHO MONICA project. Stroke, 1997,28:500-506
[53] Huikuri HV,Castellanos A,Myerburg RJ. Sudden death due to cardiac arrhyt mias.N Engl J Med, 2001, 345: 1473-1482
[54] Schleifer SJ.The nature and course of depression following myoemardialinfarction Arch Intern Med,1998,149:1785
[55]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:104
[56]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:147
[57] Growe J M ,Runions J ,Ebbesen LS ,et al. Anxiety and depression after alute myocardial infarction. Heart - lung ,1996 ,25 (2) :98
[58] Kaufmann MW , Fitzgibbons J P , Sussman EJ ,et al. Relation between myocardial infarction , depression , hostility and death. Am Heart, 1999 ,138(3):549
[59] Kwachi I,Colditz CA, Ascherio A,et a1.Proapective study of phobic Bxiety and risk of commonary heart disease in men Cerculation, 1994, 89 (5):1992-1997
[60]侯放,王金英,刘英侠.情绪障碍与冠心病后心律失常发生率的相关性研究.现代康复,2001,2(5):96
[61]王福军,慈书平.焦虑情绪对冠心病心律失常的影响.中国行为医学科学,2004,13(5):535
[62]杨菊贤.心血管疾病患者中焦虑和抑郁躯体症状的类型.上海预防医学杂志, 2002,14(2):9-13
[63]孙海霞,杨蕴萍.焦虑障碍共病抑郁的治疗进展.中国行为医学科学, 2003,12 (4):9-11
[64]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:497-507
[65]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:497-507
[66]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:110
[67]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:13-232
[68] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第一版:199-203
[69]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[70] Sanguinetti,MC,Benneit P B.Antiarrhythmic dnug target choices and screening.Circ Res,2003,93(6):491-499
[71]顾振纶,戴德哉.心血管药理学新论.北京:人们卫生出版社,2004,第一版: 139-162
[72] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第一版:199-203
[73]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[74]国家中医药管理局胸痹急症协作组.胸痹心悸(冠心病心律失常)中医急症诊疗规范.中国中医急症,1995,4(4):181-189.
[75]徐惠梅,蔡大鑫,杨平.安律胶囊治疗冠心病所致早搏30例.临床观察黑龙江中医药,2008,37(3):5-6
[76]陈兴权.疏肝益气活血法治疗冠心病所致早搏40例.四川中医,2008, 1(26):63
[77]华愫,杨霞.益肾宁心方治疗冠心病所致早搏86例.山东中医杂志,2005, 24(9):534-535
[78]李振生,冯奕超.养心定神汤加减治疗冠心病所致早搏.山西中医,2005, 3(21):7
[79]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:135
[80]李先荣,康永,程霞,等.注射用黄芪多糖药理作用的研究.中成药,1989,11(4):33
[81]程桂荣,易胜中.黄芪预处理大鼠心肌保护效应的实验研究.高血压杂志,2001,9(4):316
[82]石刚刚,陈锦香,李长潮,等.黄芪注射液对冠状动脉直接作用的研究.中药新药与临床药理,1999,10(1):38
[83]施海明,戴瑞鸿,范维琥.利多卡因和黄芪对心室晚电位的干预作用.中国中西医结合杂志,1994,14(10):598-600
[84]李先荣,康永,程霞,等.注射用黄芪多糖药理作用的研究.中成药,1989,11(4):33
[85]周吉燕.黄芪中不同提取成分对在体大鼠心肌缺血再灌注损伤的心功能影响.中国中药杂志,2000,25(5):300.
[86]刘艳霞,刘在萍,焦建杰,等.黄芪苷对正常和心功能受抑制大鼠左心室心肌力学的影响.中草药,2001,32(4):332.
[87]高健,徐先祥,徐先俊,等.黄芪总皂苷抗血栓形成作用实验研究.中成药,2002,24(2):116
[88]蒋斗发,殷昌好,俞能高,等.黄芪总皂苷对老年大鼠血液流变性的影响.基层中药杂志,2002,16(5):15
[89]庄晓燕,赵艳,王建华,等.黄芪对老年人血清羟脯氨酸含量影响的研究.锦州医学学报,2001,22(1):10
[90]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:2032
[91]徐国钧.生药学.北京:人民卫生出版社,1994,第一版:250-251
[92]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:32
[93]董昆山.现代临床中药学.北京:中国中医药出版社,1998,第一版: 390.
[94]王浴生.中药药理应用.北京:人民卫生出版社,1983,第一版: 400.
[95]阿部博子.地黄及八味地黄丸的药效药理.国外医学中医中药分册,1992,14 (2):18.
[96]于震,王军,李更生,等.地黄苷D滋阴补血和降血糖作用的实验研究.辽宁中医杂志,2001,28(4):240-241.
[97]刘鹤香,曹中亮,常东明,等.怀地黄的降压镇静抗炎作用及有效部分分析.新乡医学院学报,1998,15(3):219-221
[98]梁爱华,薛宝云,王金华.鲜地黄与干地黄止血和免疫作用比较研究.中国中药杂志,1999,24(11):663-666.
[99]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:2308
[100]李新芳,吴勇杰,郭朝晖,等.18-β甘草次酸钠对实验性心律失常的影响.中国中药杂志.1992,17(3):35
[101]郭春花.甘草酸钾和阿托品抗藜芦碱实验性心律失常作用.长治医学院学报,1998,12,4(12):251
[102]沈映君.中药药理学.北京:人民卫生出版社,2002,第一版:891
[103]吴芹.川芎嗪对离体豚鼠心房的作用特点.遵义医学院学报,1996,19(1):8
[104]黄燮南.川芎嗪舒血管作用的部位差异性及其对钙释放的抑制.中国药理学与毒理杂志,1997,11(3):199-201
[105]濮哲络.中药川芎嗪拮抗内皮素-1致冠脉收缩效应的初步观察.中国医学科学院学报,1996,18(2):133
[106]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:877
[107]抗心律失常中药的电生理学研究近况.世界科学技术—中药现代化学术进展动态,2001,3(5):41
[108]沈映君.中药药理学.北京:人民卫生出版社,2002,第一版:213
[109]沈映君.中药药理学.北京:人民卫生出版社,2002,第一版:212
[110]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:2025
[111]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:452
[112]鲁志兵.心肌梗死后交感神经重构与室性心律失常.中国心脏起博与心电生理杂志,2005,19(5):395-397
[113]唐炯,但立峰.心脏交感神经重构与心律失常:新兴领域的当前认识.心血管病学进展,2006,27(5):616-619
[114] Klamath M V,Vpton A R,Talalla A, et al.Effect of vagal never elect restinulation on the power spectrum of heart rate variability in man PACE,1992,15:235-242.
[115] KienzlM G,Fergnson D W,Briquette C L.Clinical hemodynamic and sympathetic neuralcorrelate of heart rate variability in congestive heart failure AM J Cardiol, 1992,59:261-270
[116]高美雯,刘志华.昼夜因素对心率变异的影响.苏州医学院学报,2000,20:239
[117]于锋,单德仲,王兴帮.冠心病患者的心率变异与冠状动脉病变和心肌缺血的关系.中华高血压杂志,2007,15(3):248-251
[118]杨菊贤.心血管疾病患者中焦虑和抑郁躯体症状的类型.上海预防医学杂志, 2002,14(2):9-13.
[119]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[120] Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Zipes DP, Libby P, Bonow RO,Braunwald E, ed. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th edn. Elsevier Saunders Company, Philadelphia, PA, 2004: 865-908.
[121] Essebag V, Eisenberg MJ. Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness. Card Electrophysiol Rev,2003,7: 43-48.
[122]杨跃进. BNP在心力衰竭的诊治中的临床应用研究进展.继续医学教育, 2006,20:47-54.
[123] Januzzi J L J R, Camargo C A, Anwaruddin S, et al. The N-terminal pro-BNP investiation of dyspnea in the emerency department (PRIDE) study. Am J Cardiol, 2005,95(8): 948-954.
[124] Wieczorek S J, Wu A H, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J, 2002,144:834-839.
[125] Bay M,Kirk V,Parner J,et al.NTproBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.Heart,2003,89(2): 150-154.
[126] Nielsen OW,McDonagh TA,Robb SD,et al.Retrospective analysis of the costeffectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population. Am Coll Cardiol,2003,41(1):113-120.
[127] Hedberg P,Lonnberg I,Jonason T,et al.Electrocardiogram and Btype natriuretic peptide as screening tools for left ventricular systolic dysfunction in a populationbased sample of 75yearold men and women.Am Heart,2004,148(3):524-529.
[128] Richards AM,Nicholls MG,Espiner EA,et al.Btype natriuretic peptidesand ejection fraction for prognosis after myocardial infarction.Circu- lation,2003,107(22):2786-2792.
[129]周珊珊,蔡智荣.N末端BNP前体对老年人不典型心力衰竭诊断价值.青岛大学医学院学报,2008,44(6):480-482
[130] Krüger S,Graf J,Kunz D,et al.Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure.J Am Coll Cardiol,2002,40(4):718-722.
[131] Kistorp C,Raymond I,Pedersen F,et al.Nterminal probrain natriuretic peptide,Creactive protein,and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.JAMA,2005,293(13):1609-1616
[132] MeCullough PA,Omland T,Maisel AS,et al.Rev Cardiovasc Med,2003,107:1764-1769
[133] Yancy CW,Saltzberg MT,Berkowitz RL,et al.Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).Am J Cardiol,2004,94(5): 595-601
[134]李世强,傅向华,刘君,等.静脉注射重组人脑利钠肽对急性心肌梗死伴心力衰竭患者的急性血流动力学效应的研究.中华心血管病杂志,2006,34(1):2327
[135]李为民,冯微微,刘巍.扩大降NT-BNP治疗与标准化治疗对老年充血性心力衰竭患者预后的比较研究.中国心血管网http://www.365heart.com/html/2008/09/2008090213000200039078.shtml
[1]王薇,赵冬.我国心血管病及其主要危险因素的流行病学研究.首都医科大学学报,2005,2(26):140-146
[2] Pedoe T H, Kuulasmaa K, Mahonen M, et al. Contribution of survival and coronary-event rates tochanges in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations.Lancet,1999,353:1547-1557
[3] Thorvaldsen P, Kuulasmaa K, Rajakangas A M, et al. Stroke trends in the WHO MONICA project. Stroke,1997,28:500-506
[4] Huikuri HV,Castellanos A,Myerburg RJ. Sudden death due to cardiac arrhyt mias.N Engl JMed, 2001,345: 1473-1482.
[5] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第1版:150-190
[6]陈灏珠.实用内科学.北京:人民卫生出版社,2005,第12版:1365-1366
[7] Cinca J,Warren M,Carreno A,et al.Changes in myocardial electrical impedance induced by coronary artery occlusion in pigs with and without preconditioning:correlation with local ST-segment potential and ventricular arrhythmias. Circulation 1997,96:3079-3086
[8] Coronel R,Fiolet JWT,Wilms-Schopman FJG,et al.Distribution of extracellular potassium and its relation to electrophysiologic changes during acute myocardial ischemia in the isolated perfused porcineheart.Circulation 1988,77:1125-1138
[9] Janse MJ, Van Capelle FJL, Morsink H ,et al. Flow of“injury”current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts. Evidence for two different arrhythmogenic mechanisms. Circ Res 1980,47: 151-165.
[10] De Groot JR,Wilms-Schopman FJG,Opthof T,et al. Late ventricular arrhythmias during acute regional ischemia in the isolated blood perfused pig heart.Role of electrical cellular coupling.Cardiovasc Res 2001, 50:362-372
[11] Wu J,Zipes DP.Transmural reentry during global acute ischemia and reperfusion in canine ventricular muscle,Am J Physiol 2001,280: 2717- 2725
[12] Coronel R,Wilms-Schopman FJG.de Groot JR Origin of ischemia-induced Ib arrythmias in pig hearts,J Am Coll Cardiol 2002,39:166-176
[13] Durrer JD,Lie KI,van Capelle FJL,er al.Effect of sodiumnitroprusside on mortality in acute myocardial infarction.New Engl J Med 1982,306: 1121-1128
[14] Wu J,Zipes DP.Transmural reentry triggered by epicardial and not endocardial stimulation during acute ischemia in canine ventricular muscle.Am J Physiol 2002,283:2004-2011
[15] De Bakker JMT,Coronel R,Tasseron S,et al. Ventricular tachycardia in the infarcted,Langendordd-perfused human heart:role of the arrang- ement of surviving cardiac fibers.J Am Coll Cardiol 1990,15:1594-1607
[16] De Bakker JMT,van Capelle FJL, Janse MJ,et al. Slow conduction in the infracted human heart.“Zigzag”course of activation. Circulation 1993,88:915-926.
[17] Ramdat Misier A, Opthof T, van Hemel NM,et al. Dispersion in“refractoriness”in noninfarcted myocardium of patients withventricular tachycardia or fibrillation after myocardial infarction. Circulation 1995, 91:2566-2572.
[18] Takahashi T, van Dessel P, Lopshire J,et al. Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction. Heart Rhythm, 2004,4:451-459.
[19]鲁志兵.心肌梗死后交感神经重构与室性心律失常.中国心脏起博与心电生理杂志,2005,19(5):395-397
[20]唐炯,但立峰.心脏交感神经重构与心律失常:新兴领域的当前认识.心血管病学进展,2006,27(5):616-619
[21] Janse MJ, Schwartz PJ,Wilms-Schopman F, et a1.Effects of unilateral stellat ganglion stimulation and ablation on electrophysiologic changes induced by acut myocardial ischemia in dogs.Circulation, 1985, 72: 585-595
[22] Brandys JC,Hopkins DA, Armour JA. Cardiac responses to stimulation of discrete lociwithin canine sympathetic ganglia following hexameth- onium. JAutonNerv Sys,1984,11: 243-255
[23] Cardinal R,Scherlag BJ,Vermeulen M, et a1.Distinctactivation patt- erns of idioventricular rhythms and sympathetically-induced ventricular tachycardias in dogs with atrioventricularblock. PacingClin Electro- physiol,1992,15: 1300-1316
[24] Kiriazis H,Du XJ,Feng X, et a1.Preserved left ventricular structure and function inmicewith cardiac sympathetic hyperinnervation.Am Physiol Hear Circ Physiol,2005,289:1359-1365
[25] Kreusser MM,Haass M,Buss SJ, et a1.Injection ofnerve growth factor into stellate ganglia improves norepinephrine re-uptake into failing hearts.Hypertension, 2006,47: 209-215
[26] Sybil TL,Gina GT, Susan JB.Nerve growth factormodulates synaptic transmission between sympathetic neurons and cardiacmyocytes. JNeurosc, 1997,17(24): 9573-9582
[27] Kaye DM,Vaddadi G,Gruskin SL, et a1.Reducedmyocardialnerve growth factor expression in human and experimentalheart failure.CircRes,2000, 86:80-84
[28]Ieda M,Fukuda K,Hisaka Y, et a1.Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression.JClin Inves, 2004, 113: 876-884
[29] Luisi AJ,Fallavollita JA, Suzuki G, et a1. Spatial in homogeneity of sympathetic nerve function in hibernatingmyocardium.Circulation, 2002, 106: 779-781.
[30] Cao JM,FishbeinMC,Han JB, et a1.Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation, 2000, 101: 1960-1969
[31] Cao JM, Chen LS, KenKnight BH, et a1.Nerve sprouting and sudden cardiac death.Circ Res, 2000, 86: 816-821
[32] Zhou SM, Chen LS,Miyauchi Y, et a1.Mechanisms of cardiac nerve sprouting aftermyocardial infarction in dogs.Circ Res, 2004, 95: 76-83
[33]曹克将,陈椿.抗心律失常药物的应用进展.中国实用内科杂志,2007,7(l):14-17
[34]郝静梅,戴德哉.Ⅲ类抗心律失常药物研究近况.药学进展,2004,28(5):199
[35]杜冠华.抗心律失常药物筛选研究进展.哈尔滨商业大学学报(自然科学版),2005,21(5):537
[36]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第1版:13-232
[37] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第1版:199-203
[38]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第1版:205-222
[39] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第1版:199-203
[40]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社. 2006,第1版:205-222
[41]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社. 2006,第1版:205-222
[42]顾振纶,戴德哉.心血管药理学新论.北京:人们卫生出版社,2004,第1版:139-162
[43] SANGUINETTI,MC,BENNEIT P B.Antiarrhythmic dnug target choices and screening.Circ Res,2003,93(6):491-499
[44]国家中医药管理局胸痹急症协作组,胸痹心悸(冠心病心律失常)中医急症诊疗规范.中国中医急症,1995,4(4):181-189
[45]徐惠梅,蔡大鑫,杨平.安律胶囊治疗冠心病早搏30例.临床观察黑龙江中医药,2008,37(3):5-6
[46]陈兴权.疏肝益气活血法治疗冠心病早搏40例.四川中医,2008, 1(26):63
[47]华愫,杨霞.益肾宁心方治疗冠心病早搏86例.山东中医杂志,2005, 24(9):534-535
[48]冯文娜.炙甘草汤治疗冠心病早搏86例.中国民间疗法, 2008, 10(5):30
[49]李振生,冯奕超.养心定神汤加减治疗冠心病早搏.山西中医,2005,3(21):7
[50]韩志君,齐晶.常用抗心律失常中药作用机制的研究进展.中医药信息,2007,2(24):21-23
[2]胡大一.抗心律失常药物的合理应用.北京:中国环境出版社,1997,第一版:1
[3] Huikuri HV,Castellanos A,Myerburg RJ. Sudden death due to cardiac arrhyt mias.N Engl J Med, 2001, 345: 1473-1482.
[4] Chugh SS Jui J,Gunson K,et al.Current burden of sudden cardiac death:multiple source surveillance versus retrospective death certicate-based review in a large U.S.community.J Am Coll Cardiol 2004,44:1268-1275
[5]张年顺等.李东垣医学全书.北京:中国中医药出版社,2006,第一版:336
[6]金·李东垣撰.文魁,丁国华整理.脾胃论.北京:人民卫生出版社,2005,第一版:8
[7]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:441
[8]张年顺等.李东垣医学全书.北京:中国中医药出版社,2006,第一版:336
[9]张年顺.释“阴火”.河南中医,1983,2(2):17
[10]金·李东垣撰.文魁,丁国华整理.脾胃论.北京:人民卫生出版社,2005,第一版:97
[11]姜春华.姜春华论医集.福州:福建科学技术出版社,1982,第一版:305
[12]宋乃光.刘完素医学全书.北京:中国中医药出版社.2006,第一版:312-314
[13]程畅和,朱向东.相火理论源流考辨.甘肃中医学院学报,2003,20(3):12- 14
[14]郑洪新.张元素医学全书.北京:中国中医药出版社,2006,第一版:83-85
[15]王新华.中国历代医话选.南京:江苏科学技术出版社.1983,第一版:203
[16]印会河.高等医药院校教材:中医基础理论.上海:上海科学技术出版社,1984,第一版:42-43
[17]元·朱震亨.格致余论.沈阳:辽宁科学技术出版社,1997,第一版:1
[18]清·莫枚士.研经言·君火相火辨.南京:江苏科学技术出版社:11
[19]张年顺等.李东垣医学全书.北京:中国中医药出版社,2006,第1版:337
[20]程畅和,朱向东.相火理论源流考辨.甘肃中医学院学报,2003,20(3):12- 14
[21]杨卫东.东垣“阴火”与丹溪“相火”之异同.中医研究,2006,19(8):3- 4
[22]周亚萍,赵国仁.阴火与相火的关系辨析.浙江中医杂志,2007,42(3):127-128
[23]张年顺.释“阴火”.河南中医,1983,2(2):17
[24]郭刚,陆春玲.心脏病从脾胃论治,中国中西医结合脾胃杂志,2000, (8)6:453
[25]周文献.心病从脾(胃)论治探析,中医研究,2001, 6(14): 9
[26]李连成,高荣林.从脾胃论治胸痹的理论意义.中国中医基础医学杂志,1996,4(1):38
[27]丁光迪.东垣学说论文集.北京:人民卫生出版社,1984,第一版:10
[28]金·李东垣撰.文魁,丁国华整理.脾胃论.北京:人民卫生出版社,2005,第一版:97
[29]丁光迪.东垣学说论文集.北京:人民卫生出版社,1984,第一版:11-89
[30]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:138
[31]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:135
[32]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:131-139
[33]中华人民共和国卫生部制定发布.中药新药临床研究指导原则(第二辑).中药新药治疗心悸的临床研究指导原则:91
[34]国际心脏病学会和协会及WHO临床命名标准化联合专题组.缺血性心脏病命名及诊断标准.中华心血管病杂志,1981,9(1)∶75-76.
[35]中西医结合防治冠心病心绞痛、心律失常研究座谈会制定.常见心律失常、严重程度及疗效参考标准,上海,1979年
[36]陈灏珠.实用内科学,第12版.北京:人民卫生出版社,2005,第一版:1366-1367
[37]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[38]中华人民共和国卫生部.中药新药临床研究指导原则(第二辑).1995:91
[39]国家中医药管理局胸痹急症协作组.胸痹心悸(冠心病心律失常)中医急症诊疗规范.中国中医急症,1995,4(4):181-189
[40]中华人民共和国卫生部.中药新药临床研究指导原则(第二辑).1995:91
[41]吴以岭,谷春华,高学东,等.参松养心胶囊治疗冠心病室性早搏的随机双盲多中心临床研究.疑难病杂志,2007,8(6):449-452
[42]中华心血管病杂志编委会心率变异性对策专题组.心率变异性检测临床应用的建议.中华心血管病杂志,1998,26(4):252-255
[43]中华人民共和国卫生部.中药新药临床研究指导原则(第二辑).1995:91
[44]张钊,杨守忠,毛绍芬.参龙宁心胶囊联合阿替洛尔治疗冠心病心律失常临床研究.光明中医,2008,4(23):479
[45]中华人民共和国卫生部.中药新药临床研究指导原则.第一辑.1993:29
[46]陈可冀.心脑血管研究.上海:上海科技出版社,1998,第一版:311
[47]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:236-253
[48]路英智,张勤锋,田明萍.33例功能性消化不良的心理检测和治疗.中国行为医学科学,2000,5(9):19-20
[49]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:235
[50]王薇,赵冬.我国心血管病及其主要危险因素的流行病学研究.首都医科大学学报,2005,2(26):140-146
[51] Pedoe T H, Kuulasmaa K, Mahonen M, et al. Contribution of survival and coronary-event rates tochanges in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations.Lancet, 1999,353:1547-1557
[52] Thorvaldsen P, Kuulasmaa K, Rajakangas A M, et al. Stroke trends in the WHO MONICA project. Stroke, 1997,28:500-506
[53] Huikuri HV,Castellanos A,Myerburg RJ. Sudden death due to cardiac arrhyt mias.N Engl J Med, 2001, 345: 1473-1482
[54] Schleifer SJ.The nature and course of depression following myoemardialinfarction Arch Intern Med,1998,149:1785
[55]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:104
[56]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:147
[57] Growe J M ,Runions J ,Ebbesen LS ,et al. Anxiety and depression after alute myocardial infarction. Heart - lung ,1996 ,25 (2) :98
[58] Kaufmann MW , Fitzgibbons J P , Sussman EJ ,et al. Relation between myocardial infarction , depression , hostility and death. Am Heart, 1999 ,138(3):549
[59] Kwachi I,Colditz CA, Ascherio A,et a1.Proapective study of phobic Bxiety and risk of commonary heart disease in men Cerculation, 1994, 89 (5):1992-1997
[60]侯放,王金英,刘英侠.情绪障碍与冠心病后心律失常发生率的相关性研究.现代康复,2001,2(5):96
[61]王福军,慈书平.焦虑情绪对冠心病心律失常的影响.中国行为医学科学,2004,13(5):535
[62]杨菊贤.心血管疾病患者中焦虑和抑郁躯体症状的类型.上海预防医学杂志, 2002,14(2):9-13
[63]孙海霞,杨蕴萍.焦虑障碍共病抑郁的治疗进展.中国行为医学科学, 2003,12 (4):9-11
[64]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:497-507
[65]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:497-507
[66]胡大一.心脏病人精神卫生培训教程.北京:人民军医出版社,2006,第一版:110
[67]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第一版:13-232
[68] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第一版:199-203
[69]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[70] Sanguinetti,MC,Benneit P B.Antiarrhythmic dnug target choices and screening.Circ Res,2003,93(6):491-499
[71]顾振纶,戴德哉.心血管药理学新论.北京:人们卫生出版社,2004,第一版: 139-162
[72] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第一版:199-203
[73]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[74]国家中医药管理局胸痹急症协作组.胸痹心悸(冠心病心律失常)中医急症诊疗规范.中国中医急症,1995,4(4):181-189.
[75]徐惠梅,蔡大鑫,杨平.安律胶囊治疗冠心病所致早搏30例.临床观察黑龙江中医药,2008,37(3):5-6
[76]陈兴权.疏肝益气活血法治疗冠心病所致早搏40例.四川中医,2008, 1(26):63
[77]华愫,杨霞.益肾宁心方治疗冠心病所致早搏86例.山东中医杂志,2005, 24(9):534-535
[78]李振生,冯奕超.养心定神汤加减治疗冠心病所致早搏.山西中医,2005, 3(21):7
[79]周仲英.新世纪全国高等中医药院校规划教材:中医内科学.北京:中国中医药出版社,2005,第一版:135
[80]李先荣,康永,程霞,等.注射用黄芪多糖药理作用的研究.中成药,1989,11(4):33
[81]程桂荣,易胜中.黄芪预处理大鼠心肌保护效应的实验研究.高血压杂志,2001,9(4):316
[82]石刚刚,陈锦香,李长潮,等.黄芪注射液对冠状动脉直接作用的研究.中药新药与临床药理,1999,10(1):38
[83]施海明,戴瑞鸿,范维琥.利多卡因和黄芪对心室晚电位的干预作用.中国中西医结合杂志,1994,14(10):598-600
[84]李先荣,康永,程霞,等.注射用黄芪多糖药理作用的研究.中成药,1989,11(4):33
[85]周吉燕.黄芪中不同提取成分对在体大鼠心肌缺血再灌注损伤的心功能影响.中国中药杂志,2000,25(5):300.
[86]刘艳霞,刘在萍,焦建杰,等.黄芪苷对正常和心功能受抑制大鼠左心室心肌力学的影响.中草药,2001,32(4):332.
[87]高健,徐先祥,徐先俊,等.黄芪总皂苷抗血栓形成作用实验研究.中成药,2002,24(2):116
[88]蒋斗发,殷昌好,俞能高,等.黄芪总皂苷对老年大鼠血液流变性的影响.基层中药杂志,2002,16(5):15
[89]庄晓燕,赵艳,王建华,等.黄芪对老年人血清羟脯氨酸含量影响的研究.锦州医学学报,2001,22(1):10
[90]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:2032
[91]徐国钧.生药学.北京:人民卫生出版社,1994,第一版:250-251
[92]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:32
[93]董昆山.现代临床中药学.北京:中国中医药出版社,1998,第一版: 390.
[94]王浴生.中药药理应用.北京:人民卫生出版社,1983,第一版: 400.
[95]阿部博子.地黄及八味地黄丸的药效药理.国外医学中医中药分册,1992,14 (2):18.
[96]于震,王军,李更生,等.地黄苷D滋阴补血和降血糖作用的实验研究.辽宁中医杂志,2001,28(4):240-241.
[97]刘鹤香,曹中亮,常东明,等.怀地黄的降压镇静抗炎作用及有效部分分析.新乡医学院学报,1998,15(3):219-221
[98]梁爱华,薛宝云,王金华.鲜地黄与干地黄止血和免疫作用比较研究.中国中药杂志,1999,24(11):663-666.
[99]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:2308
[100]李新芳,吴勇杰,郭朝晖,等.18-β甘草次酸钠对实验性心律失常的影响.中国中药杂志.1992,17(3):35
[101]郭春花.甘草酸钾和阿托品抗藜芦碱实验性心律失常作用.长治医学院学报,1998,12,4(12):251
[102]沈映君.中药药理学.北京:人民卫生出版社,2002,第一版:891
[103]吴芹.川芎嗪对离体豚鼠心房的作用特点.遵义医学院学报,1996,19(1):8
[104]黄燮南.川芎嗪舒血管作用的部位差异性及其对钙释放的抑制.中国药理学与毒理杂志,1997,11(3):199-201
[105]濮哲络.中药川芎嗪拮抗内皮素-1致冠脉收缩效应的初步观察.中国医学科学院学报,1996,18(2):133
[106]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:877
[107]抗心律失常中药的电生理学研究近况.世界科学技术—中药现代化学术进展动态,2001,3(5):41
[108]沈映君.中药药理学.北京:人民卫生出版社,2002,第一版:213
[109]沈映君.中药药理学.北京:人民卫生出版社,2002,第一版:212
[110]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:2025
[111]江苏新医学院.中药大词典.上海:上海科学技术出版社,1986,第一版:452
[112]鲁志兵.心肌梗死后交感神经重构与室性心律失常.中国心脏起博与心电生理杂志,2005,19(5):395-397
[113]唐炯,但立峰.心脏交感神经重构与心律失常:新兴领域的当前认识.心血管病学进展,2006,27(5):616-619
[114] Klamath M V,Vpton A R,Talalla A, et al.Effect of vagal never elect restinulation on the power spectrum of heart rate variability in man PACE,1992,15:235-242.
[115] KienzlM G,Fergnson D W,Briquette C L.Clinical hemodynamic and sympathetic neuralcorrelate of heart rate variability in congestive heart failure AM J Cardiol, 1992,59:261-270
[116]高美雯,刘志华.昼夜因素对心率变异的影响.苏州医学院学报,2000,20:239
[117]于锋,单德仲,王兴帮.冠心病患者的心率变异与冠状动脉病变和心肌缺血的关系.中华高血压杂志,2007,15(3):248-251
[118]杨菊贤.心血管疾病患者中焦虑和抑郁躯体症状的类型.上海预防医学杂志, 2002,14(2):9-13.
[119]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第一版:205-222
[120] Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Zipes DP, Libby P, Bonow RO,Braunwald E, ed. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th edn. Elsevier Saunders Company, Philadelphia, PA, 2004: 865-908.
[121] Essebag V, Eisenberg MJ. Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness. Card Electrophysiol Rev,2003,7: 43-48.
[122]杨跃进. BNP在心力衰竭的诊治中的临床应用研究进展.继续医学教育, 2006,20:47-54.
[123] Januzzi J L J R, Camargo C A, Anwaruddin S, et al. The N-terminal pro-BNP investiation of dyspnea in the emerency department (PRIDE) study. Am J Cardiol, 2005,95(8): 948-954.
[124] Wieczorek S J, Wu A H, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J, 2002,144:834-839.
[125] Bay M,Kirk V,Parner J,et al.NTproBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.Heart,2003,89(2): 150-154.
[126] Nielsen OW,McDonagh TA,Robb SD,et al.Retrospective analysis of the costeffectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population. Am Coll Cardiol,2003,41(1):113-120.
[127] Hedberg P,Lonnberg I,Jonason T,et al.Electrocardiogram and Btype natriuretic peptide as screening tools for left ventricular systolic dysfunction in a populationbased sample of 75yearold men and women.Am Heart,2004,148(3):524-529.
[128] Richards AM,Nicholls MG,Espiner EA,et al.Btype natriuretic peptidesand ejection fraction for prognosis after myocardial infarction.Circu- lation,2003,107(22):2786-2792.
[129]周珊珊,蔡智荣.N末端BNP前体对老年人不典型心力衰竭诊断价值.青岛大学医学院学报,2008,44(6):480-482
[130] Krüger S,Graf J,Kunz D,et al.Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure.J Am Coll Cardiol,2002,40(4):718-722.
[131] Kistorp C,Raymond I,Pedersen F,et al.Nterminal probrain natriuretic peptide,Creactive protein,and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.JAMA,2005,293(13):1609-1616
[132] MeCullough PA,Omland T,Maisel AS,et al.Rev Cardiovasc Med,2003,107:1764-1769
[133] Yancy CW,Saltzberg MT,Berkowitz RL,et al.Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).Am J Cardiol,2004,94(5): 595-601
[134]李世强,傅向华,刘君,等.静脉注射重组人脑利钠肽对急性心肌梗死伴心力衰竭患者的急性血流动力学效应的研究.中华心血管病杂志,2006,34(1):2327
[135]李为民,冯微微,刘巍.扩大降NT-BNP治疗与标准化治疗对老年充血性心力衰竭患者预后的比较研究.中国心血管网http://www.365heart.com/html/2008/09/2008090213000200039078.shtml
[1]王薇,赵冬.我国心血管病及其主要危险因素的流行病学研究.首都医科大学学报,2005,2(26):140-146
[2] Pedoe T H, Kuulasmaa K, Mahonen M, et al. Contribution of survival and coronary-event rates tochanges in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations.Lancet,1999,353:1547-1557
[3] Thorvaldsen P, Kuulasmaa K, Rajakangas A M, et al. Stroke trends in the WHO MONICA project. Stroke,1997,28:500-506
[4] Huikuri HV,Castellanos A,Myerburg RJ. Sudden death due to cardiac arrhyt mias.N Engl JMed, 2001,345: 1473-1482.
[5] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第1版:150-190
[6]陈灏珠.实用内科学.北京:人民卫生出版社,2005,第12版:1365-1366
[7] Cinca J,Warren M,Carreno A,et al.Changes in myocardial electrical impedance induced by coronary artery occlusion in pigs with and without preconditioning:correlation with local ST-segment potential and ventricular arrhythmias. Circulation 1997,96:3079-3086
[8] Coronel R,Fiolet JWT,Wilms-Schopman FJG,et al.Distribution of extracellular potassium and its relation to electrophysiologic changes during acute myocardial ischemia in the isolated perfused porcineheart.Circulation 1988,77:1125-1138
[9] Janse MJ, Van Capelle FJL, Morsink H ,et al. Flow of“injury”current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts. Evidence for two different arrhythmogenic mechanisms. Circ Res 1980,47: 151-165.
[10] De Groot JR,Wilms-Schopman FJG,Opthof T,et al. Late ventricular arrhythmias during acute regional ischemia in the isolated blood perfused pig heart.Role of electrical cellular coupling.Cardiovasc Res 2001, 50:362-372
[11] Wu J,Zipes DP.Transmural reentry during global acute ischemia and reperfusion in canine ventricular muscle,Am J Physiol 2001,280: 2717- 2725
[12] Coronel R,Wilms-Schopman FJG.de Groot JR Origin of ischemia-induced Ib arrythmias in pig hearts,J Am Coll Cardiol 2002,39:166-176
[13] Durrer JD,Lie KI,van Capelle FJL,er al.Effect of sodiumnitroprusside on mortality in acute myocardial infarction.New Engl J Med 1982,306: 1121-1128
[14] Wu J,Zipes DP.Transmural reentry triggered by epicardial and not endocardial stimulation during acute ischemia in canine ventricular muscle.Am J Physiol 2002,283:2004-2011
[15] De Bakker JMT,Coronel R,Tasseron S,et al. Ventricular tachycardia in the infarcted,Langendordd-perfused human heart:role of the arrang- ement of surviving cardiac fibers.J Am Coll Cardiol 1990,15:1594-1607
[16] De Bakker JMT,van Capelle FJL, Janse MJ,et al. Slow conduction in the infracted human heart.“Zigzag”course of activation. Circulation 1993,88:915-926.
[17] Ramdat Misier A, Opthof T, van Hemel NM,et al. Dispersion in“refractoriness”in noninfarcted myocardium of patients withventricular tachycardia or fibrillation after myocardial infarction. Circulation 1995, 91:2566-2572.
[18] Takahashi T, van Dessel P, Lopshire J,et al. Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction. Heart Rhythm, 2004,4:451-459.
[19]鲁志兵.心肌梗死后交感神经重构与室性心律失常.中国心脏起博与心电生理杂志,2005,19(5):395-397
[20]唐炯,但立峰.心脏交感神经重构与心律失常:新兴领域的当前认识.心血管病学进展,2006,27(5):616-619
[21] Janse MJ, Schwartz PJ,Wilms-Schopman F, et a1.Effects of unilateral stellat ganglion stimulation and ablation on electrophysiologic changes induced by acut myocardial ischemia in dogs.Circulation, 1985, 72: 585-595
[22] Brandys JC,Hopkins DA, Armour JA. Cardiac responses to stimulation of discrete lociwithin canine sympathetic ganglia following hexameth- onium. JAutonNerv Sys,1984,11: 243-255
[23] Cardinal R,Scherlag BJ,Vermeulen M, et a1.Distinctactivation patt- erns of idioventricular rhythms and sympathetically-induced ventricular tachycardias in dogs with atrioventricularblock. PacingClin Electro- physiol,1992,15: 1300-1316
[24] Kiriazis H,Du XJ,Feng X, et a1.Preserved left ventricular structure and function inmicewith cardiac sympathetic hyperinnervation.Am Physiol Hear Circ Physiol,2005,289:1359-1365
[25] Kreusser MM,Haass M,Buss SJ, et a1.Injection ofnerve growth factor into stellate ganglia improves norepinephrine re-uptake into failing hearts.Hypertension, 2006,47: 209-215
[26] Sybil TL,Gina GT, Susan JB.Nerve growth factormodulates synaptic transmission between sympathetic neurons and cardiacmyocytes. JNeurosc, 1997,17(24): 9573-9582
[27] Kaye DM,Vaddadi G,Gruskin SL, et a1.Reducedmyocardialnerve growth factor expression in human and experimentalheart failure.CircRes,2000, 86:80-84
[28]Ieda M,Fukuda K,Hisaka Y, et a1.Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression.JClin Inves, 2004, 113: 876-884
[29] Luisi AJ,Fallavollita JA, Suzuki G, et a1. Spatial in homogeneity of sympathetic nerve function in hibernatingmyocardium.Circulation, 2002, 106: 779-781.
[30] Cao JM,FishbeinMC,Han JB, et a1.Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation, 2000, 101: 1960-1969
[31] Cao JM, Chen LS, KenKnight BH, et a1.Nerve sprouting and sudden cardiac death.Circ Res, 2000, 86: 816-821
[32] Zhou SM, Chen LS,Miyauchi Y, et a1.Mechanisms of cardiac nerve sprouting aftermyocardial infarction in dogs.Circ Res, 2004, 95: 76-83
[33]曹克将,陈椿.抗心律失常药物的应用进展.中国实用内科杂志,2007,7(l):14-17
[34]郝静梅,戴德哉.Ⅲ类抗心律失常药物研究近况.药学进展,2004,28(5):199
[35]杜冠华.抗心律失常药物筛选研究进展.哈尔滨商业大学学报(自然科学版),2005,21(5):537
[36]齐晓勇,李树仁,张建清.心律失常.北京:军事医学科学出版社,2007,第1版:13-232
[37] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第1版:199-203
[38]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社,2006,第1版:205-222
[39] Silvia G.Priori Douglas P.Zipes原著,刘文玲主译.心脏性猝死临床实践手册.北京:人们卫生出版社,2007,第1版:199-203
[40]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社. 2006,第1版:205-222
[41]陈韵岱,吕树铮.临床心血管病学循证医学问答.北京:人民军医出版社. 2006,第1版:205-222
[42]顾振纶,戴德哉.心血管药理学新论.北京:人们卫生出版社,2004,第1版:139-162
[43] SANGUINETTI,MC,BENNEIT P B.Antiarrhythmic dnug target choices and screening.Circ Res,2003,93(6):491-499
[44]国家中医药管理局胸痹急症协作组,胸痹心悸(冠心病心律失常)中医急症诊疗规范.中国中医急症,1995,4(4):181-189
[45]徐惠梅,蔡大鑫,杨平.安律胶囊治疗冠心病早搏30例.临床观察黑龙江中医药,2008,37(3):5-6
[46]陈兴权.疏肝益气活血法治疗冠心病早搏40例.四川中医,2008, 1(26):63
[47]华愫,杨霞.益肾宁心方治疗冠心病早搏86例.山东中医杂志,2005, 24(9):534-535
[48]冯文娜.炙甘草汤治疗冠心病早搏86例.中国民间疗法, 2008, 10(5):30
[49]李振生,冯奕超.养心定神汤加减治疗冠心病早搏.山西中医,2005,3(21):7
[50]韩志君,齐晶.常用抗心律失常中药作用机制的研究进展.中医药信息,2007,2(24):21-23